Purple Biotech Stock (NASDAQ: PPBT) stock price, news, charts, stock research, profile.
Open | $0.37 |
Close | $0.37 |
Volume / Avg. | 86.43K / 338.87K |
Day Range | 0.36 - 0.39 |
52 Wk Range | 0.30 - 1.80 |
Market Cap | $12.68M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Purple Biotech (NASDAQ:PPBT) through any online brokerage.
Other companies in Purple Biotech’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Universe Pharmaceuticals (NASDAQ:UPC).
There is no analysis for Purple Biotech.
Purple Biotech has a consensus price target of $10.00.
The stock price for Purple Biotech (NASDAQ: PPBT) is $0.374 last updated July 19, 2024 at 7:53 PM EDT.
There are no upcoming dividends for Purple Biotech.
Purple Biotech’s Q2 earnings are confirmed for Tuesday, August 20, 2024.
There is no upcoming split for Purple Biotech.
Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.